(Q77763125)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Resistance mutations selected in vivo under therapy with anti-HIV drug HBY 097 differ from resistance pattern selected in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

H Rübsamen-Waigmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

E Huguenel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A Shah

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A Paessens

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H J Ruoff

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H von Briesen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A Immelmann

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M A Wainberg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

15-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

HIV‐1‐specific RT inhibitors: Highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

What can be Expected from Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) in the Treatment of Human Immunodeficiency Virus Type 1 (HIV-1) Infections?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Mutational analysis of residue 190 of human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

1 reference

7 January 2021

In vitro selection for different mutational patterns in the HIV-1 reverse transcriptase using high and low selective pressure of the nonnucleoside reverse transcriptase inhibitor HBY 097.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Clinical correlates of in vitro HIV-1 resistance ot zidovudine. Results of the Multicentre Canadian AZT Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Markers for HIV-disease progression in untreated patients and patients receiving AZT: Evaluation of viral activity, AZT resistance, serum cholesterol, β2-microglobulin, CD4+ cell counts, and HIV antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Standard Conditions of Virus Isolation Reveal Biological Variability of HIV Type 1 in Different Regions of the World

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Second-generation non-nucleosidic reverse transcriptase inhibitor HBY097 and HIV-1 viral load

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Comparison of cord blood and peripheral blood mononuclear cells as targets for viral isolation and drug sensitivity studies involving human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Combination therapy with zidovudine prevents selection of human immunodeficiency virus type 1 variants expressing high-level resistance to L-697,661, a nonnucleoside reverse transcriptase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Isolation frequency and growth properties of HIV-variants: multiple simultaneous variants in a patient demonstrated by molecular cloning.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Systematic classification of HIV biological subtypes on lymphocytes and monocytes/macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900010-8

7 January 2021

10.1016/S0166-3542(99)00010-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10333139%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference